Summary
CNBC’s Jim Cramer discusses a wave of analyst downgrades across homebuilders, arguing that high rates and elevated monthly payments are crushing starter-home demand and leaving the group without traction. The video also includes opening-bell mentions of Tortoise Capital’s AI Infrastructure ETF and Atlas Pharma, plus a brief incomplete Maduro/Chevron reference.
- Wells Fargo downgrades D.R. Horton; UBS downgrades Lennar and cuts KBH's price target.
- Cramer says rates remain too high relative to prior lows.
- He argues starter-home monthly costs are too elevated for buyers to engage.
- Homebuilders are described as unable to gain traction despite cheap-looking prices.
- The opening bell segment highlights Tortoise Capital's AI Infrastructure ETF launch.
- Atlas Pharma is noted for a recent listing and name change.
- The anchor observes the VIX around 15 and a calm market tone.
- Cramer begins a brief, incomplete Maduro/Chevron-related market comment before the transcript ends.